» Articles » PMID: 35204963

Presentation of Congenital Portosystemic Shunts in Children

Overview
Specialty Health Services
Date 2022 Feb 25
PMID 35204963
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Congenital portosystemic shunts (CPSS) are rare vascular anomalies resulting in communications between the portal venous system and the systemic venous circulation, affecting an estimated 30,000 to 50,000 live births. CPSS can present at any age as a multi-system disease of variable severity mimicking both common and rare pediatric conditions.

Case Presentations: Case A: A vascular malformation was identified in the liver of a 10-year-old girl with tall stature, advanced somatic maturation, insulin resistance with hyperinsulinemia, hyperandrogenemia and transient hematuria. Work-up also suggested elevated pulmonary pressures. Case B: A young girl with trisomy 8 mosaicism with a history of neonatal hypoglycemia, transient neonatal cholestasis and tall stature presented newly increased aminotransferase levels at 6 years of age. Case C: A 3-year-old boy with speech delay, tall stature and abdominal pain underwent abdominal ultrasound (US) showing multiple liver nodules, diagnosed as liver hemangiomas by hepatic magnetic resonance imaging (MRI). Management and outcome: After identification of a venous malformation on liver Doppler US, all three patients were referred to a specialized liver center for further work-up within 12 to 18 months from diagnosis. Angio-computed tomography (CT) scan confirmed the presence of either an intrahepatic or extrahepatic CPSS with multiples liver nodules. All three had a hyperintense signal in the globus pallidus on T1 weighted cerebral MRI. Right heart catheterization confirmed pulmonary hypertension in cases A and C. Shunts were closed either using an endovascular or surgical approach. Liver nodules were either surgically removed if there was a risk of malignant degeneration or closely monitored by serial imaging when benign.

Conclusion: These cases illustrate most of the common chief complaints and manifestations of CPSS. Liver Doppler US is the key to diagnosis. Considering portosystemic shunts in the diagnostic work-up of a patient with unexplained endocrine, liver, gastro-intestinal, cardiovascular, hematological, renal or neurocognitive disorder is important as prompt referral to a specialized center may significantly impact patient outcome.

Citing Articles

Long-term follow-up and transcatheter embolization of extrahepatic congenital portosystemic shunt with shifting hemodynamics.

Hatakeyama K, Tozawa T, Noguchi A, Mori N J Clin Imaging Sci. 2025; 15:9.

PMID: 40041437 PMC: 11878720. DOI: 10.25259/JCIS_156_2024.


Effect of Daily Fiber Intake Among Cirrhotic Patients With and Without Portosystemic Shunts.

Parisse S, Carnevale S, Damato E, Ferri F, Mischitelli M, Corona M Curr Dev Nutr. 2025; 9(1):104527.

PMID: 39896732 PMC: 11787017. DOI: 10.1016/j.cdnut.2024.104527.


Congenital intrahepatic portosystemic shunt in 27 children: an experience and treatment strategy of a single centre in China.

Zhang J Front Pediatr. 2024; 12:1428270.

PMID: 39670191 PMC: 11634595. DOI: 10.3389/fped.2024.1428270.


Case Report: Management of a congenital intrahepatic portosystemic shunt with portal vein aneurysm in a child using 3D computer-assisted partial right hepatectomy.

Liu Y, Arief J, Xiu W, Hao X, Wang F, Xia N Front Pediatr. 2024; 12:1429537.

PMID: 39529963 PMC: 11550969. DOI: 10.3389/fped.2024.1429537.


Congenital portosystemic shunts: experience of a tertiary Tunisian referral center.

Jerbi B, Chourou H, Ben Aziza R, Jelassi O, Sdiri Y, Belhadj Ammar W AJOG Glob Rep. 2024; 4(4):100409.

PMID: 39512762 PMC: 11541822. DOI: 10.1016/j.xagr.2024.100409.


References
1.
Sokollik C, Bandsma R, Gana J, van den Heuvel M, Ling S . Congenital portosystemic shunt: characterization of a multisystem disease. J Pediatr Gastroenterol Nutr. 2013; 56(6):675-81. DOI: 10.1097/MPG.0b013e31828b3750. View

2.
Zhang J, Fallon M . Hepatopulmonary syndrome: update on pathogenesis and clinical features. Nat Rev Gastroenterol Hepatol. 2012; 9(9):539-49. PMC: 10963041. DOI: 10.1038/nrgastro.2012.123. View

3.
Satoh M, Yokoya S, Hachiya Y, Hachiya M, Fujisawa T, Hoshino K . Two hyperandrogenic adolescent girls with congenital portosystemic shunt. Eur J Pediatr. 2001; 160(5):307-11. DOI: 10.1007/s004310000539. View

4.
Srivastava A, Chaturvedi S, Gupta R, Malik R, Mathias A, Jagannathan N . Minimal hepatic encephalopathy in children with chronic liver disease: Prevalence, pathogenesis and magnetic resonance-based diagnosis. J Hepatol. 2016; 66(3):528-536. DOI: 10.1016/j.jhep.2016.10.026. View

5.
He X, Zhu Y, Fu H, Feng C, Liu Z, Gu W . Case Report: Membranoproliferative Glomerulonephritis, a Rare Clinical Manifestation of Abernethy Malformation Type II. Front Pediatr. 2021; 9:647364. PMC: 8010253. DOI: 10.3389/fped.2021.647364. View